Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 03 Aug 2026
Standard TKI doses are often too high for long-term care. Dr Mark Kris shares his strategy for smart dose reductions that protect patient outcomes.
Read Full News1.
Alternative breast imaging techniques beyond mammography.
2.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
3.
Capivasertib Wins Metastatic Prostate Cancer Approval
4.
Fixed-Duration Combo Shows Promise for Relapsed MCL
5.
Q&A: Breast cancer facts that could save lives
1.
Hematopoietic Stem Cell Activity Biomarkers in Aging
2.
Clonal Hematopoiesis and Healthy Aging: Insights, Mechanisms, and Clinical Relevance
3.
Guidance for Monitoring Iron Overload
4.
Emerging Dysregulated Signaling Pathways in Early-Onset Colorectal Cancer
5.
The Role of Calcium Corrections in Accurate Blood Test Results
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
2.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
3.
Navigating the Complexities of Ph Negative ALL - Part III
4.
Recognizing Symptoms That May Require Cancer Evaluation
5.
First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge